Differential Expression of CHL1 Gene during Development of Major Human Cancers

Background CHL1 gene (also known as CALL) on 3p26.3 encodes a one-pass trans-membrane cell adhesion molecule (CAM). Previously CAMs of this type, including L1, were shown to be involved in cancer growth and metastasis. Methodology/Principal Findings We used Clontech Cancer Profiling Arrays (19 different types of cancers, 395 samples) to analyze expression of the CHL1 gene. The results were further validated by RT-qPCR for breast, renal and lung cancer. Cancer Profiling Arrays revealed differential expression of the gene: down-regulation/silencing in a majority of primary tumors and up-regulation associated with invasive/metastatic growth. Frequent down-regulation (>40% of cases) was detected in 11 types of cancer (breast, kidney, rectum, colon, thyroid, stomach, skin, small intestine, bladder, vulva and pancreatic cancer) and frequent up-regulation (>40% of cases) – in 5 types (lung, ovary, uterus, liver and trachea) of cancer. Using real-time quantitative PCR (RT-qPCR) we found that CHL1 expression was decreased in 61% of breast, 60% of lung, 87% of clear cell and 89% papillary renal cancer specimens (P<0.03 for all the cases). There was a higher frequency of CHL1 mRNA decrease in lung squamous cell carcinoma compared to adenocarcinoma (81% vs. 38%, P = 0.02) without association with tumor progression. Conclusions/Significance Our results suggested that CHL1 is involved in the development of different human cancers. Initially, during the primary tumor growth CHL1 could act as a putative tumor suppressor and is silenced to facilitate in situ tumor growth for 11 cancer types. We also suggested that re-expression of the gene on the edge of tumor mass might promote local invasive growth and enable further metastatic spread in ovary, colon and breast cancer. Our data also supported the role of CHL1 as a potentially novel specific biomarker in the early pathogenesis of two major histological types of renal cancer.

[1]  F. Entschladen,et al.  Cell Communication and Signaling BioMed Central Review Extravasation of leukocytes in comparison to tumor cells , 2008 .

[2]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[3]  P. Altevogt,et al.  L1, a novel target of β-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers , 2005, The Journal of cell biology.

[4]  S. Ogawa,et al.  Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms , 2009, Nature.

[5]  R. Tibshirani,et al.  Repeated observation of breast tumor subtypes in independent gene expression data sets , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Joshua F. McMichael,et al.  Genome Remodeling in a Basal-like Breast Cancer Metastasis and Xenograft , 2010, Nature.

[7]  P. Sham,et al.  Single‐nucleotide polymorphism‐mass array reveals commonly deleted regions at 3p22 and 3p14.2 associate with poor clinical outcome in esophageal squamous cell carcinoma , 2008, International journal of cancer.

[8]  Kerstin Lang,et al.  Tumour-cell migration, invasion, and metastasis: navigation by neurotransmitters. , 2004, The Lancet. Oncology.

[9]  R. Eils,et al.  Systemic spread is an early step in breast cancer. , 2008, Cancer cell.

[10]  O. Migita,et al.  An association between a missense polymorphism in the close homologue of L1 (CHL1, CALL) gene and schizophrenia , 2002, Molecular Psychiatry.

[11]  T. Barrette,et al.  ONCOMINE: a cancer microarray database and integrated data-mining platform. , 2004, Neoplasia.

[12]  E. Sausville,et al.  Transcription profiling of gene expression in drug discovery and development: the NCI experience. , 2004, European journal of cancer.

[13]  U. Cavallaro,et al.  The adhesion molecule L1 regulates transendothelial migration and trafficking of dendritic cells , 2009, The Journal of experimental medicine.

[14]  Kathleen R. Cho,et al.  Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas. , 2006, Cancer research.

[15]  J. Minna,et al.  Construction of a 600-kilobase cosmid clone contig and generation of a transcriptional map surrounding the lung cancer tumor suppressor gene (TSG) locus on human chromosome 3p21.3: progress toward the isolation of a lung cancer TSG. , 1996, Cancer research.

[16]  R. Weller,et al.  International Histological Classification of Tumours , 1981 .

[17]  A. Protopopov,et al.  An integrated physical and gene map of the 3.5-Mb chromosome 3p21.3 (AP20) region implicated in major human epithelial malignancies. , 2003, Cancer research.

[18]  Amy E. Hawkins,et al.  DNA sequencing of a cytogenetically normal acute myeloid leukemia genome , 2008, Nature.

[19]  E. Birney,et al.  Patterns of somatic mutation in human cancer genomes , 2007, Nature.

[20]  S. Rha,et al.  Whole genome analysis for liver metastasis gene signatures in colorectal cancer , 2007, International journal of cancer.

[21]  G. Parmigiani,et al.  The Consensus Coding Sequences of Human Breast and Colorectal Cancers , 2006, Science.

[22]  N. Socci,et al.  Gene expression profiling allows distinction between primary and metastatic squamous cell carcinomas in the lung. , 2005, Cancer research.

[23]  P. Hermanek.  TNM atlas : Illustrated guide to the TNM/pTNM classification of malignant tumours , 1997 .

[24]  M. Newton,et al.  Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers. , 2007, Cancer research.

[25]  Gösta Winberg,et al.  RBSP3 (HYA22) is a tumor suppressor gene implicated in major epithelial malignancies. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[26]  M. Schachner,et al.  Overexpression of the cell adhesion molecule L1 is associated with metastasis in cutaneous malignant melanoma. , 2002, European journal of cancer.

[27]  Christian A. Rees,et al.  Systematic variation in gene expression patterns in human cancer cell lines , 2000, Nature Genetics.

[28]  R. D'Hooge,et al.  CALL interrupted in a patient with non-specific mental retardation: gene dosage-dependent alteration of murine brain development and behavior. , 2003, Human molecular genetics.

[29]  K. Pantel,et al.  Cancer micrometastases , 2009, Nature Reviews Clinical Oncology.

[30]  Quynh-Thu Le,et al.  Lysyl oxidase is essential for hypoxia-induced metastasis , 2006, Nature.

[31]  T. Yeatman,et al.  Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer , 2007, Genome Biology.

[32]  E. Gillanders,et al.  Hereditary prostate cancer in Finland: fine-mapping validates 3p26 as a major predisposition locus , 2004, Human Genetics.

[33]  宁北芳,et al.  疟原虫var基因转换速率变化导致抗原变异[英]／Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A , 2005 .

[34]  Börje Ljungberg,et al.  High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas , 2009, BMC Cancer.

[35]  E. Birney,et al.  Patterns of somatic mutation in human cancer genomes , 2007, Nature.

[36]  A. Mes-Masson,et al.  Molecular Genetic Analysis of a Cell Adhesion Molecule With Homology to L1CAM, Contactin 6, and Contactin 4 Candidate Chromosome 3p26pter Tumor Suppressor Genes in Ovarian Cancer , 2009, International Journal of Gynecologic Cancer.

[37]  M. Lerman,et al.  Simultaneous down-regulation of tumor suppressor genes RBSP3/CTDSPL, NPRL2/G21 and RASSF1A in primary non-small cell lung cancer , 2010, BMC Cancer.

[38]  J. Eisen,et al.  In silico-initiated cloning and molecular characterization of a novel human member of the L1 gene family of neural cell adhesion molecules , 1998, Human Genetics.

[39]  B. Spiessl.  TNM atlas : illustrated guide to the TNM/pTNM-classification of malignant tumours , 1989 .

[40]  Y. Shimosato,et al.  Histological Typing of Lung and Pleural Tumours , 1999, World Health Organization.

[41]  Tsviya Olender,et al.  GeneCardsTM 2002: towards a complete, object-oriented, human gene compendium , 2002, Bioinform..

[42]  M. Mareel,et al.  Clinical, cellular, and molecular aspects of cancer invasion. , 2003, Physiological reviews.

[43]  H. Tang,et al.  Actin-based protrusions: promoters or inhibitors of cancer invasion? , 2009, Cancer cell.

[44]  E. Zabarovsky,et al.  Downregulation of RBSP3/CTDSPL, NPRL2/G21, RASSF1A, ITGA9, HYAL1, and HYAL2 in non-small cell lung cancer , 2008, Molecular Biology.

[45]  Arianna Di Napoli,et al.  Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney. , 2009, Cancer research.

[46]  A. Godwin,et al.  The differential role of L1 in ovarian carcinoma and normal ovarian surface epithelium. , 2008, Cancer research.

[47]  Elaine Fuchs,et al.  Cyfip1 Is a Putative Invasion Suppressor in Epithelial Cancers , 2009, Cell.

[48]  G. Krasnov,et al.  [Down-regulation of RBSP3/CTDSPL, NPRL2/G21, RASSF1A, ITGA9, HYAL1 and HYAL2 genes in non-small cell lung cancer]. , 2008, Molekuliarnaia biologiia.

[49]  I sabel Mortara,et al.  International Union against Cancer , 1938, Nature.

[50]  M. Wei,et al.  CALL gene is haploinsufficient in a 3p- syndrome patient. , 1999, American journal of medical genetics.

[51]  P. Altevogt,et al.  L1 on ovarian carcinoma cells is a binding partner for Neuropilin-1 on mesothelial cells. , 2006, Cancer letters.

[52]  Jon W. Huss,et al.  BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources , 2009, Genome Biology.

[53]  E. Kinney.  Primer of Biostatistics , 1987 .

[54]  Deon Venter,et al.  The gene associated with trichorhinophalangeal syndrome in humans is overexpressed in breast cancer. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[55]  J. Minna,et al.  Discovery of frequent homozygous deletions in chromosome 3p21.3 LUCA and AP20 regions in renal, lung and breast carcinomas , 2004, Oncogene.

[56]  B. Ljung,et al.  Deletion of two separate regions on chromosome 3p in breast cancers. , 1994, Cancer research.

[57]  D. Botstein,et al.  Variation in gene expression patterns in human gastric cancers. , 2003, Molecular biology of the cell.

[58]  B. Olsson,et al.  Evaluation of Combining Several Statistical Methods with a Flexible Cutoff for Identifying Differentially Expressed Genes in Pairwise Comparison of EST Sets , 2008, Bioinformatics and biology insights.

[59]  Stephen A Bustin,et al.  Reliability of real-time reverse-transcription PCR in clinical diagnostics: gold standard or substandard? , 2009, Expert review of molecular diagnostics.